Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 57.99

-0.3%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (1226)	6/23/2000 5:39:00 PM
From: scaram(o)uche	of 52153

>> Anyone else who knows about it care to comment? << I was rather intimate with the original GenPharm-CEGE conflict, and yet I don't have a clue. Pretty certain that IR at ABGX will tell you. Why wouldn't they give you a simple, straightforward answer? By osmosis, I have learned that MEDX has no rights to the ABGX improvements. Dunno, however, if I had my head in a bucket of liquid gold or pure p*ss. Being too close to MAbs, I've never caught this "they're magic" disease. Therefore have never owned either ABGX or MEDX. Oh, the pain.........

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next